Vestcor Inc Has $1.07 Million Holdings in Envista Holdings Co. (NYSE:NVST)

Vestcor Inc lifted its position in shares of Envista Holdings Co. (NYSE:NVST - Free Report) by 344.4% during the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 54,249 shares of the company's stock after buying an additional 42,041 shares during the period. Vestcor Inc's holdings in Envista were worth $1,072,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of NVST. M&T Bank Corp boosted its stake in Envista by 42.9% in the 3rd quarter. M&T Bank Corp now owns 15,945 shares of the company's stock worth $315,000 after buying an additional 4,787 shares during the last quarter. XTX Topco Ltd purchased a new position in shares of Envista during the 3rd quarter worth about $704,000. Villanova Investment Management Co LLC purchased a new position in shares of Envista during the 3rd quarter worth about $1,066,000. Readystate Asset Management LP boosted its position in shares of Envista by 16.7% in the third quarter. Readystate Asset Management LP now owns 51,016 shares of the company's stock worth $1,008,000 after acquiring an additional 7,288 shares during the last quarter. Finally, Point72 Asset Management L.P. purchased a new stake in Envista in the third quarter valued at approximately $37,559,000.

Analyst Ratings Changes

A number of analysts have recently issued reports on the company. Needham & Company LLC reiterated a "hold" rating on shares of Envista in a report on Thursday, October 31st. Wells Fargo & Company began coverage on shares of Envista in a research note on Tuesday, October 8th. They set an "equal weight" rating and a $20.00 price objective for the company. Mizuho assumed coverage on shares of Envista in a research note on Wednesday, December 4th. They issued an "underperform" rating and a $20.00 target price on the stock. Leerink Partners upgraded Envista from an "underperform" rating to a "market perform" rating and increased their price target for the company from $16.00 to $23.00 in a report on Thursday, October 31st. Finally, Leerink Partnrs upgraded Envista from a "strong sell" rating to a "hold" rating in a research note on Thursday, October 31st. Two analysts have rated the stock with a sell rating, eleven have given a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, Envista presently has a consensus rating of "Hold" and a consensus target price of $20.65.

Envista Stock Performance

Envista stock traded down $0.83 during mid-day trading on Friday, hitting $19.47. 1,680,303 shares of the company's stock traded hands, compared to its average volume of 2,367,129. The company has a quick ratio of 1.77, a current ratio of 2.08 and a debt-to-equity ratio of 0.42. Envista Holdings Co. has a one year low of $15.15 and a one year high of $25.64. The firm has a 50 day moving average price of $20.07 and a 200 day moving average price of $18.43. The company has a market cap of $3.35 billion, a PE ratio of -2.51, a price-to-earnings-growth ratio of 2.86 and a beta of 1.31.

Envista (NYSE:NVST - Get Free Report) last released its quarterly earnings results on Wednesday, October 30th. The company reported $0.12 EPS for the quarter, topping analysts' consensus estimates of $0.09 by $0.03. Envista had a negative net margin of 53.42% and a positive return on equity of 3.76%. The company had revenue of $601.00 million for the quarter, compared to the consensus estimate of $590.34 million. During the same period in the previous year, the firm earned $0.43 EPS. Envista's revenue was down 4.8% on a year-over-year basis. On average, equities analysts forecast that Envista Holdings Co. will post 0.72 EPS for the current year.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.